SCHEMBL29975474

SCHEMBL29975474

COc1cc(Nc2ncc(Br)c(Nc3cccc4c3C(=O)CCC4)n2)c(C)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.54
▸ ALK Q9UM73 10/20 0.52
▸ INSR P06213 9/20 0.52
▸ IGF1R P08069 9/20 0.52
▸ PLK1 P53350 2/20 0.47
▸ PTK2 Q05397 2/20 0.47
▸ CHEK1 O14757 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ NUAK1 O60285 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ STK10 O94804 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ SLC34A2 O95436 1/20 0.47
▸ CHEK2 O96017 1/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ CD74 P04233 1/20 0.47
▸ ERBB2 P04626 1/20 0.47
▸ LCK P06239 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ FES P07332 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29084169 0.93 EGFR (0.63) EGFRALKINSRIGF1RPTK2
SCHEMBL29084044 0.88 EGFR (0.65) EGFRALKINSRIGF1RPTK2
SCHEMBL29084065 0.86 EGFR (0.53) EGFRALKINSRIGF1RPLK1
SCHEMBL29084133 0.86 EGFR (0.55) EGFRALKINSRIGF1RPTK2
SCHEMBL29084115 0.83 ALK (0.66) EGFRALKINSRIGF1RPLK1
SCHEMBL29084052 0.82 EGFR (0.61) EGFRALKINSRIGF1RPTK2
SCHEMBL29084066 0.82 EGFR (0.55) EGFRALKINSRIGF1RPLK1
SCHEMBL29083964 0.81 EGFR (0.53) EGFRALKINSRIGF1R
SCHEMBL29083941 0.81 EGFR (0.55) EGFRALKINSRIGF1RPLK1
SCHEMBL29974686 0.81 EGFR (0.52) EGFRALKINSRIGF1RFGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO claimed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO disclosed
Send feedback